Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) srt2:(2000-2004);srt2:(2003)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) > (2000-2004) > (2003)

Sortera/gruppera träfflistan
  • Hansen, S, et al. (författare)
  • Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type I in breast cancer patients
  • 2003
  • Ingår i: British Journal of Cancer. - Nature Publishing Group. - 1532-1827. ; 88:1, s. 102-108
  • Tidskriftsartikel (refereegranskat)abstract
    • Tumour angiogenesis and the levels of plasminogen activator inhibitor type I (PAI-I) are both informative prognostic markers in breast cancer. In cell cultures and in animal model systems, PAI-I has a proangiogenic effect. To evaluate the interrelationship of angiogenesis and the PAI-I level in breast cancer, we have evaluated the prognostic value of those factors in a total of 228 patients with primary, unilateral, invasive breast cancer, evaluated at a median follow-up time of 12 years. Microvessels were immunohistochemically stained by antibodies against CD34 and quantitated by the Chalkley counting technique. The levels of PAI-I and its target proteinase uPA in tumour extracts were analysed by ELISA. The Chalkley count was not correlated with the levels of uPA or PAI-I. High values of uPA, PAI-I, and Chalkley count were all significantly correlated with a shorter recurrence-free survival and overall survival. In the multivariate analysis, the uPA level did not show independent prognostic impact for any of the analysed end points. In contrast, the risk of recurrence was independently and significantly predicted by both the PAI-I level and the Chalkley count, with a hazard ratio (95% CI) of 1.6 (1.01-2.69) and 1.4 (1.02-1.81), respectively. For overall survival, the Chalkley count, but not PAI-I, was of significant independent prognostic value. The risk of death was 1.7 (1,30-2.15) for Chalkley counts in the upper tertile compared to the lower one. We conclude that the PAI-I level and the Chalkley count are independent prognostic markers for recurrence-free survival in patients with primary breast cancer, suggesting that the prognostic impact of PAI-I is not only based on its involvement in angiogenesis. (C) 2003 Cancer Research UK.
  • He, ZY, et al. (författare)
  • None of the integrins known to be present on the mouse egg or to be ADAM receptors are essential for sperm-egg binding and fusion
  • 2003
  • Ingår i: Developmental Biology. - Elsevier. - 1095-564X. ; 254:2, s. 226-237
  • Tidskriftsartikel (refereegranskat)abstract
    • Antibody inhibition and alpha6beta1 ligand binding experiments indicate that the egg integrin alpha6beta1 functions as a receptor for sperm during gamete fusion; yet, eggs null for the alpha6 integrin exhibit normal fertilization. Alternative integrins may be involved in sperm-egg binding and fusion and could compensate for the absence of alpha6beta1. Various beta1 integrins and alphav integrins are present on mouse eggs. Some of these integrins are also reported to be receptors for ADAMs, which are expressed on sperm. Using alpha3 integrin null eggs, we found that the alpha3beta1 integrin was not essential for sperm-egg binding and fusion. Oocyte-specific, beta1 integrin conditional knockout mice allowed us to obtain mature eggs lacking all beta1 integrins. We found that the beta1 integrin null eggs were fully functional in fertilization both in vivo and in vitro. Furthermore, neither anti-mouse beta3 integrin function-blocking monoclonal antibody (mAb) nor alphav integrin function-blocking mAb inhibited sperm binding to or fusion with beta1 integrin null eggs. Thus, function of beta3 or alphav integrins does not seem to be involved in compensating for the absence of beta1 integrins. These results indicate that none of the integrins known to be present on mouse eggs or to be ADAM receptors are essential for sperm-egg binding/fusion, and thus, egg integrins may not play the role in gamete fusion previously attributed to them.
  • Hedberg, Y, et al. (författare)
  • Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
  • 2003
  • Ingår i: British Journal of Cancer. - Nature Publishing Group. - 1532-1827. ; 88:9, s. 1417-1423
  • Tidskriftsartikel (refereegranskat)abstract
    • Aberrations in the GI/S transition of the cell cycle have been observed in many malignancies and seem to be critical in the transformation process. Few studies have delineated the presence of GI/S regulatory defects and their clinical relevance in renal cell carcinoma (RCC). Therefore, we have examined the protein contents of cyclin D 1, D3, E, and p27 in 218 RCCs, using tissue microarray and immunohistochemistry. The results from a subset of tumours were confirmed by Western blotting and immunohistochemical staining of regular tissue sections. Interestingly, low protein contents of cyclin D I and p27 were associated with high nuclear grade, large tumour size, and poor prognosis for patients with conventional tumours. We further observed substantial differences in the pattern of GI/S regulatory defects between the different RCC subtypes. The majority of both conventional and papillary cases expressed p27; however, chromophobe tumours generally lacked p27 staining. In addition, conventional RCCs often expressed high cyclin DI protein levels, while papillary RCCs exhibited high cyclin E. In summary, we have shown that GI/S regulatory defects are present in RCC and are associated with clinico-pathological parameters. The pattern of cell cycle regulatory defects also differed between RCC subtypes. (C) 2003 Cancer Research UK.
  • Hedenfalk, Ingrid, et al. (författare)
  • Molecular classification of familial non-BRCA1/BRCA2 breast cancer
  • 2003
  • Ingår i: Proceedings of the National Academy of Sciences. - National Acad Sciences. - 1091-6490. ; 100:5, s. 2532-2537
  • Tidskriftsartikel (refereegranskat)abstract
    • In the decade since their discovery, the two major breast cancer susceptibility genes BRCA1 and BRCA2, have been shown conclusively to be involved in a significant fraction of families segregating breast and ovarian cancer. However, it has become equally clear that a large proportion of families segregating breast cancer alone are not caused by mutations in BRCA1 or BRCA2. Unfortunately, despite intensive effort, the identification of additional breast cancer predisposition genes has so far been unsuccessful, presumably because of genetic heterogeneity, low penetrance, or recessive/polygenic mechanisms. These non-BRCA1/2 breast cancer families (termed BRCAx families) comprise a histopathologically heterogeneous group, further supporting their origin from multiple genetic events. Accordingly, the identification of a method to successfully subdivide BRCAx families into recognizable groups could be of considerable value to further genetic analysis. We have previously shown that global gene expression analysis can identify unique and distinct expression profiles in breast tumors from BRCA1 and BRCA2 mutation carriers. Here we show that gene expression profiling can discover novel classes among BRCAx tumors, and differentiate them from BRCA1 and BRCA2 tumors. Moreover, microarray-based comparative genomic hybridization (CGH) to cDNA arrays revealed specific somatic genetic alterations within the BRCAx subgroups. These findings illustrate that, when gene expression-based classifications are used, BRCAx families can be grouped into homogeneous subsets, thereby potentially increasing the power of conventional genetic analysis.
  • Hedlund, G Persdotter, et al. (författare)
  • Fetal antigen 1 (FA1) in the adult rat adrenal gland, ovary and pituitary gland
  • 2003
  • Ingår i: In Vivo. - In vivo. - 0258-851X. ; 17:1, s. 1-4
  • Tidskriftsartikel (refereegranskat)abstract
    • Fetal antigen 1 (FA1) is a circulating glycoprotein containing six epidermal growth factor (EGF)-like repeats. FA1's larger membrane-bound precursor is defined by the cDNAs referred to as either human delta-like (dlk) or human adrenal specific cDNA, pG2. In rodents FA1 has also been studied under the names of preadipocyte factor 1 (Pref-1), and zona glomerulosa-specific factor (ZOG). FA1 is abundantly expressed in fetal tissues, but in the mature cells of the adult organism the tissue presence of the protein seems to be restricted to neuroendocrine tissues. The present study demonstrates FA1 localisation in endocrine tissues of the adult female rat in which the protein was found present in the medulla and the zona glomerulosa of the cortex of the adrenal glands, in the pars distalis of the adenohypophysis, and in the ovarian granulosa lutein cells. No staining was found in the pancreas, which is in contrast to what has been described in the human.
Skapa referenser, mejla, bekava och länka
fritt online (56)
Typ av publikation
tidskriftsartikel (220)
doktorsavhandling (12)
konferensbidrag (7)
forskningsöversikt (6)
bokkapitel (4)
Typ av innehåll
refereegranskat (231)
övrigt vetenskapligt (23)
Olsson, Håkan, (12)
Fernö, Mårten, (11)
Landberg, Göran, (9)
Li, Xinjun, (8)
Stenram, Unne, (7)
Bendahl, Pär Ola, (7)
visa fler...
Baldetorp, Bo, (7)
Mertens, Fredrik, (7)
Mattsson, Sören, (7)
Svanberg, Sune, (6)
Svanberg, Katarina, (6)
Borg, Åke, (6)
Hemminki, Kari, (6)
Möller, Torgil, (6)
Anderson, Harald (6)
Påhlman, Sven, (5)
Strand, Sven-Erik, (5)
Pålsson, Sara, (5)
Turesson, I, (4)
Hultborn, Ragnar, 19 ... (4)
Andersson-Engels, St ... (4)
Karlsson, Mikael, (4)
Larsson, Christer, (4)
Berglund, Göran, (4)
Sorokin, Lydia, (4)
Zackrisson, B (4)
Ringnér, Markus, (4)
Lindholm, C (4)
Lennernäs, Bo, 1963- ... (4)
Ringberg, Anita (3)
Gustafsson, U, (3)
Alm, Per, (3)
Tranberg, Karl-Göran ... (3)
Håkansson, J. (3)
Ringborg, U (3)
Glimelius, B, (3)
Kjellén, Elisabeth (3)
Boman, K. (3)
Hemminki, K (3)
Ahlman, Håkan, 1947- ... (3)
Wängberg, Bo, 1953-, (3)
Albertsson, Maria (3)
Gustafson, Pelle, (3)
Janciauskiene, Sabin ... (3)
Ljungberg, Michael, (3)
Alvegård, Thor, (3)
Rydholm, Anders, (3)
Gustavsson, Anita, (3)
visa färre...
Lunds universitet (191)
Göteborgs universitet (28)
Karolinska Institutet (24)
Linköpings universitet (9)
Umeå universitet (8)
Uppsala universitet (7)
visa fler...
Stockholms universitet (4)
Örebro universitet (3)
Kungliga Tekniska Högskolan (1)
Linnéuniversitetet (1)
visa färre...
Engelska (247)
Svenska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (249)
Naturvetenskap (1)
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy